ASGR1 and hepatocellular carcinoma: Meanwhile, ASGR1+ tumor-associated microparticles (taMPs) are significantly elevated in the peripheral blood of patients with HCC and cholangiocarcinoma, suggesting their potential as a novel non-invasive diagnostic tool for distinguishing liver cancer from liver cirrhosis (94).